AstraZeneca will make a first payment of $200 million and another of $120 million in consideration, for Neogene Therapeutics. AstraZeneca is building a portfolio of cell...
The current round will enable Arjuna Therapeutics to carry out its developments and later open a new round of financing on an international scale. The round...